Much remains unknown about the genetic and systems-level decision-making that guides innate and adaptive immunity to viruses and bacteria. Without that understanding there are major gaps in strategies to establish and improve vaccines against many NIH Priority Pathogens, and to interpret patterns of human genetic, cellular, and serological variation to predict the efficacy and longevity of immunity in clinical settings and in the field. The Gentics Core will produce an unparalleled resource of mouse mutations for experimental and systems analysis of innate and adaptive immunity. Over the 5 year period of this application, through a combination of forward genetics by ENU mutagenesis and pioneering methods to identify mutations by whole exome sequencing, this Core will generate and identify 210,000 single nucleotide variants that change the protein coding sequence of individual genes in live-breeding C57BL/6 mice. Greater than 80% of all annotated genes will suffer deleterious mutation, and all mutations will be archived in the form of frozen sperm for rapid retrieval. The core will supply homozygous, heterozygous and control mice to all of the Projects of this U19 program and to the broader research community. This Core, in synergy with the other Cores and Projects of this U19 program, will expand the community resource of mouse mutations and datasets that experimentally connect discrete genes with the cells and systems governing innate and adaptive immunity. These resources and datasets will be distributed to the community via repositories and websites to enable researchers to test their own hypotheses about adaptive immunity.
Immunity to viruses and bacteria, especially those representing potential bio-terrorism agents and emerging diseases, depends upon thousands of mostly unexplored genes that come together in sophisticated but poorly understood control systems. This Core will produce a unique and critical experimental resource to define these genes and systems, and thereby open the way for new technologies to promote immunity against these agents.
|Wang, Ying; Su, Lijing; Morin, Matthew D et al. (2016) TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. Proc Natl Acad Sci U S A 113:E884-93|
|Shi, Hexin; Wang, Ying; Li, Xiaohong et al. (2016) NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol 17:250-8|
|Siggs, Owen M; Stockenhuber, Alexander; Deobagkar-Lele, Mukta et al. (2016) Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity. Proc Natl Acad Sci U S A 113:E3706-15|
|Fragiadakis, Gabriela K; Baca, Quentin J; Gherardini, Pier Federico et al. (2016) Mapping the Fetomaternal Peripheral Immune System at Term Pregnancy. J Immunol 197:4482-4492|
|Wang, James Q; Beutler, Bruce; Goodnow, Christopher C et al. (2016) Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivo. Blood 128:1604-8|
|Andrews, T Daniel; Jeelall, Yogesh; Talaulikar, Dipti et al. (2016) DeepSNVMiner: a sequence analysis tool to detect emergent, rare mutations in subsets of cell populations. PeerJ 4:e2074|
|Angst, Martin S; Fragiadakis, Gabriela K; GaudilliÃ¨re, Brice et al. (2016) In Reply. Anesthesiology 124:1414-5|
|Parish, Ian A; Stamp, Lincon A; Lorenzo, Ayla May D et al. (2016) A Novel Mutation in Nucleoporin 35 Causes Murine Degenerative Colonic Smooth Muscle Myopathy. Am J Pathol 186:2254-61|
|Frei, Andreas P; Bava, Felice-Alessio; Zunder, Eli R et al. (2016) Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat Methods 13:269-75|
|Wu, Zuopeng; Liang, Rong; Ohnesorg, Thomas et al. (2016) Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion. PLoS Genet 12:e1006067|
Showing the most recent 10 out of 90 publications